[button href=”/2015agenda/2015precon/” size=”small” color=”#4542de” hovercolor=”#4f4cff” textcolor=”#FFF”]Professional Development Courses (Oct. 9-11)[/button]
[button href=”/2015agenda/2015scientific/” size=”small” color=”#4542de” hovercolor=”#4f4cff” textcolor=”#FFF”]Scientific Program (Oct. 11-14)[/button]
Certain program items have been recorded and are available for purchase.
Presentations available for download where indicated on the agenda
[testimonial author=”2015 Conference Attendeee”]I enjoyed the wide topic range of the Scientific Program and feel that I gained extremely useful knowledge from the conference.[/testimonial]
Session I
Developing a Culture of Awareness; Biological Arms Control, Dual Use Research, and
Responsible Conduct of Science (PDF 1MB)
Nancy Connell, PhD, Rutgers New Jersey Medical School, Newark, NJ
Session II
The Anatomy of an Exposure (PDF 867KB)
Thomas H. Winters, MD, FACOEM, FACPM, Harvard School of Public Health, Boston, MA
Proper Management of Incident Reporting in Biological Research Labs (PDF 1MB) (ID #210)
Brian O’Shea, PhD, CBSP, Battelle Memorial Institute, Columbus, OH
Bio-related Exposure Monitoring and Follow-up System at the University of California—San Francisco (PDF 162KB) (ID #243)
Peili Zhu, PhD, RBP, University of California—San Francisco, San Francisco, CA
Session V
Strategies for Risk Assessment and Institutional Oversight of Emerging RNAi Technologies (PDF 442KB)
Angela Birnbaum, RBP, CBSP, Harvard University, Cambridge, MA
Rebecca Caruso, MPH, RBP, CBSP, Harvard Medical School, Boston, MA
Session VI
WHO Laboratory Biosafety Manual Updates (PDF 1MB)
Kazunobu Kojima, MD, PhD, World Health Organization, Geneva Switzerland
Session VII
Biosafety and Containment Considerations for U.S. Hospitals Preparing for Ebola Virus Disease (PDF 2MB) (ID #262)
Betsy Weirich, MS, CBSP, SM(NRCM), Centers for Disease Control and Prevention, Atlanta, GA
Biosafety-Healthcare Interaction Beyond Ebola (PDF 2MB) (ID #231)
Kalpana Rengarajan, PhD, RBP, Emory University, Atlanta, GA
Avian Influenza Risk Perception among Egyptian Poultry Handlers (PDF 777KB) (ID #254)
Lamiaa A. Fiala, Faculty of Medicine, Ismailia, Egypt
Survival of Hepatitis C Virus is Temperature, Syringe Type, and Volume Dependent: Implications for Infection Control Strategies (PDF 2MB) (ID #220)
Elijah Paintsil, Yale University, New Haven, CT
Session IX
Gain-of-Function Research: The Eye of the Storm—The University of Wisconsin Story (PDF 4MB) (ID #216)
Rebecca Moritz, CBSP, University of Wisconsin—Madison, Madison, WI
Poliovirus Containment: Mitigating Facility-related Risks in the Endgame and Post-Eradication Eras (PDF 445KB) (ID #247)
Steven Oberste, PhD, Centers for Disease Control and Prevention, Atlanta, GA
Why Did the Salmonella-Spiked Chicken Cross the Auger? Adventures in Interdisciplinary Research Risk Assessment (PDF 2MB) (ID #232)
Shane Gillooly, Georgia Institute of Technology, Atlanta, GA
Session XI
National Biosafety Stewardship Month: A Glimpse into Institutional Safety Activities (PDF 204KB)
David A. Martinson, PhD, National Biosafety and Biocontainment Training Program, Bethesda, MD
Session XIII
United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (PDF 2MB) (ID #58)
Kathryn L. Harris, PhD, RBP, National Institutes of Health, Bethesda, MD
Using Peer-Review Faculty Committees to Obtain Biosafety Consensus (PDF 1MB) (ID #250)
Molly S. Stitt-Fischer, PhD, SM(NRCM), CPH, University of Pittsburgh, Pittsburgh, PA
Zombies, Mad Scientists and Superheroes: An Approach to Promoting Safety Culture with Research Lab Personnel (PDF 5MB) (ID #222)
Brandy Nelson, CBSP, University of Kentucky, Lexington, KY
Session XIV
Benefits of a Multi-pronged Teaching Module for Select Agent Required Security, Incident Response, and Biosafety Training (PDF 1MB) (ID #251)
Kathryn F. Board, University of Pittsburgh, Pittsburgh, PA
Improving Biosafety Culture—Learning Lessons from Incidents (PDF 2MB) (ID #236)
David Bryant, United Kingdom Animal and Plant Health Agency, Weybridge, Surrey, United Kingdom
How Can We Facilitate Understanding of the rDNA Guidelines to the Scientific Community? (PDF 874KB) (ID #228)
Esmeralda L. Meyer, Emory University, Atlanta, GA
Session XV
The CDC Etiologic Agent Import Permits Facility Inspection Process: Two High-containment Laboratory Experiences (PDF 3MB) (ID #225)
David S. Bressler, CBSP, Centers for Disease Control and Prevention, Atlanta, GA
Shipping and Exporting Research Materials: Yale University’s Research Material Shipping and Export Program via eShipGlobal (PDF 541KB) (ID #255)
Kevin M. Charbonneau, Yale University, New Haven, CT
Synthetic Biology: Biosafety and Biosecurity (PDF 2MB) (ID #297)
David Gillum, MS, RBP, Arizona State University, Tempe, AZ
Session XVI
Issues Identified by Commissioning, Again and Again (PDF 2MB) (ID #233)
Joby Evans, Merrick & Company, Atlanta, GA
Conversion of a Biosafety Level 3 (BSL-3) Lab to an Arthropod Containment Level 2 (ACL-2) Lab (PDF 986KB) (ID #117)
Jolly Qian, Novartis Institute for Tropical Diseases, Singapore, Singapore
Equine Facility Biosafety: Challenges and Lessons Learned from Large Animal ABSL-2 Containment (PDF 2MB) (ID #202)
Delena W. Mazzetti, MPH, RBP, University of Kentucky, Lexington, Kentucky
Biosafety Program for Animal Biosafety Level 2 Facility at University of California—San Francisco (PDF 2MB) (ID #244)
Mei-Chuan Huang, PhD, RBP, University of California—San Francisco, San Francisco, CA
Session XVII
Developing a Neurological Assessment Protocol Safe for Implementation in High- and Maximum-containment Facilities (PDF 1MB) (ID #296)
Shannon E. Ronca, BS, University of Texas Medical Branch—Galveston, Galveston, TX
Session XIX
Update from the Lab Safety Task Force (PDF 1MB)
Ara Tahmassian, PhD, Harvard University, Cambridge, MA
Leadership… and Cultures of Responsibility (PDF 2MB)
David Franz, DVM, PhD, Frederick, MD
Ebola at Emory: Keeping the Culture of Safety (PDF 2MB)
G. Marshall Lyon III, MD, MMSc, Emory University School of Medicine, Atlanta, GA
Session XX
Effectiveness of Decontamination of Laboratory Room Surfaces with Low Concentrations of Hydrogen Peroxide and Isopropyl Alcohol Using Atmospheric Cold Plasma Activation (PDF 4MB) (ID #217)
Miguel A. Grimaldo, MEng, University of Texas Medical Branch—Galveston, Galveston, TX
Aerosol Monitoring of ABSL-4 Laboratories Housing Non-Human Primates Challenged with Ebola Virus (PDF 1MB) (ID #42)
David Harbourt, PhD, RBP, U.S. Army Medical Research Institute of Infectious Disease, Fort Detrick, MD
How to Fit a Square Peg into a Round Hole: Complying with Regulatory Requirements in a BSL-3 Ag Facility (PDF 2MB) (ID #227)
Erin E. Smith, RBP, Kansas State University, Manhattan, KS
Downloadable PDFs:
[button href=”https://absaconference.org/wp-content/uploads/2015/09/ABSAProvidence2015-MondayAbstracts.pdf” size=”small” color=”#4542de” hovercolor=”#4f4cff” textcolor=”#FFF”]Monday(PDF 108KB)[/button]
[button href=”https://absaconference.org/wp-content/uploads/2015/09/ABSAProvidence2015-TuesdayAbstracts.pdf” size=”small” color=”#4542de” hovercolor=”#4f4cff” textcolor=”#FFF”]Tuesday(PDF 186KB)[/button]
[button href=”https://absaconference.org/wp-content/uploads/2015/09/ABSAProvidence2015-WednesdayAbstracts.pdf” size=”small” color=”#4542de” hovercolor=”#4f4cff” textcolor=”#FFF”]Wednesday(PDF 241KB)[/button]